The rise of clinical integration of independent health care providers is one of the most closely watched phenomena in the health care antitrust area.
As the new administration articulates its position on how to balance the care and cost benefits of clinical integration with the potential for harm to competition from the often-accompanying joint contracting, this confluence of health care policy and antitrust law only promises to get more interesting.
Reprinted with permission from Portfolio Media, Inc. (http://www.law360.com)
Author(s)
Related Insights
May 1, 2026
Manufacturing Industry Advisor
A New DOL Joint Employment Rule? What Franchisors Need to Know
On April 22, 2026, the U.S. Department of Labor's Wage and Hour Division published a proposed rule to establish a single, nationwide…
May 27, 2026
Events
ABA’s Qui Tam & Civil False Claims and Healthcare Fraud Institute 2026
Foley partner Lisa Noller, Chair of the Firm’s Litigation Department, will be speaking at the American Bar Association’s Qui Tam & Civil False Claims and Healthcare Fraud Institute in Washington, D.C. from May 27-28.
April 30, 2026
Foley Viewpoints
Sizing Up The 3-Way Battle For 'Iceman' IP Rights
Trademark rights in the U.S. arise from use in commerce, not from registration alone. The Lanham Act's first-to-use framework means that a party who can demonstrate earlier, continuous commercial use of a mark holds superior rights over a later filer. This principle is the backbone of Gervin's case against Williams.